BROOKDALE SENIOR LIVING - BKD 7 11/15/25 (BKDT) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:BKDT - US1124633025
77.6 USD
-2.09 (-2.62%)
BKDT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. BKDT has a bad profitability rating. Also its financial health evaluation is rather negative. BKDT has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year BKDT has reported negative net income.
BKDT had a positive operating cash flow in the past year.
BKDT had negative earnings in 4 of the past 5 years.
BKDT had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of BKDT (-3.19%) is comparable to the rest of the industry.
With a Return On Equity value of -95.04%, BKDT is not doing good in the industry: 76.36% of the companies in the same industry are doing better.
The Return On Invested Capital of BKDT (0.76%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.19% | ||
| ROE | -95.04% | ||
| ROIC | 0.76% |
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BKDT has a Operating Margin (1.76%) which is in line with its industry peers.
In the last couple of years the Operating Margin of BKDT has grown nicely.
Looking at the Gross Margin, with a value of 25.57%, BKDT is in line with its industry, outperforming 50.91% of the companies in the same industry.
BKDT's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.76% | ||
| PM (TTM) | N/A | ||
| GM | 25.57% |
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BKDT is destroying value.
BKDT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BKDT has been increased compared to 5 years ago.
The debt/assets ratio for BKDT has been reduced compared to a year ago.
2.2 Solvency
BKDT has an Altman-Z score of 1.14. This is a bad value and indicates that BKDT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BKDT (1.14) is worse than 63.64% of its industry peers.
A Debt/Equity ratio of 20.19 is on the high side and indicates that BKDT has dependencies on debt financing.
BKDT has a Debt to Equity ratio of 20.19. This is amonst the worse of the industry: BKDT underperforms 84.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 20.19 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.14 |
ROIC/WACC0.09
WACC8.64%
2.3 Liquidity
BKDT has a Current Ratio of 0.88. This is a bad value and indicates that BKDT is not financially healthy enough and could expect problems in meeting its short term obligations.
BKDT has a Current ratio of 0.88. This is in the lower half of the industry: BKDT underperforms 78.18% of its industry peers.
A Quick Ratio of 0.88 indicates that BKDT may have some problems paying its short term obligations.
With a Quick ratio value of 0.88, BKDT is not doing good in the industry: 70.91% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.88 |
3. Growth
3.1 Past
BKDT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.95%.
BKDT shows a small growth in Revenue. In the last year, the Revenue has grown by 3.63%.
The Revenue has been decreasing by -5.08% on average over the past years.
EPS 1Y (TTM)-5.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.5%
Revenue 1Y (TTM)3.63%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.51%
3.2 Future
BKDT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.13% yearly.
The Revenue is expected to grow by 2.10% on average over the next years.
EPS Next Y34.18%
EPS Next 2Y19.37%
EPS Next 3Y18.13%
EPS Next 5YN/A
Revenue Next Year2.75%
Revenue Next 2Y-0.46%
Revenue Next 3Y2.1%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for BKDT. In the last year negative earnings were reported.
Also next year BKDT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BKDT is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 46.27 |
4.3 Compensation for Growth
BKDT's earnings are expected to grow with 18.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.37%
EPS Next 3Y18.13%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.51%, BKDT is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.58, BKDT pays a better dividend. On top of this BKDT pays more dividend than 97.27% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, BKDT pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.51% |
5.2 History
BKDT has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y19.37%
EPS Next 3Y18.13%
BROOKDALE SENIOR LIVING - BKD 7 11/15/25
NYSE:BKDT (3/27/2025, 8:04:01 PM)
77.6
-2.09 (-2.62%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners106.89%
Inst Owner ChangeN/A
Ins Owners3.68%
Ins Owner ChangeN/A
Market Cap15.53B
Revenue(TTM)3.13B
Net Income(TTM)-201.94M
Analysts73.33
Price Target105.12 (35.46%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.51% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-50.06%
Min EPS beat(2)-74.45%
Max EPS beat(2)-25.67%
EPS beat(4)1
Avg EPS beat(4)-21.47%
Min EPS beat(4)-74.45%
Max EPS beat(4)26.45%
EPS beat(8)3
Avg EPS beat(8)-5.89%
EPS beat(12)4
Avg EPS beat(12)-2.98%
EPS beat(16)7
Avg EPS beat(16)16.88%
Revenue beat(2)0
Avg Revenue beat(2)-1.05%
Min Revenue beat(2)-1.1%
Max Revenue beat(2)-1%
Revenue beat(4)0
Avg Revenue beat(4)-1.09%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)-1%
Revenue beat(8)0
Avg Revenue beat(8)-0.88%
Revenue beat(12)0
Avg Revenue beat(12)-0.72%
Revenue beat(16)0
Avg Revenue beat(16)-1.27%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)10.25%
EPS NQ rev (3m)22.22%
EPS NY rev (1m)8.42%
EPS NY rev (3m)8.42%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)0.39%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-1.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.97 | ||
| P/FCF | N/A | ||
| P/OCF | 93.48 | ||
| P/B | 73.11 | ||
| P/tB | 83.9 | ||
| EV/EBITDA | 46.27 |
EPS(TTM)-0.89
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)0.83
OCFY1.07%
SpS15.61
BVpS1.06
TBVpS0.92
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.19% | ||
| ROE | -95.04% | ||
| ROCE | 0.96% | ||
| ROIC | 0.76% | ||
| ROICexc | 0.8% | ||
| ROICexgc | 0.81% | ||
| OM | 1.76% | ||
| PM (TTM) | N/A | ||
| GM | 25.57% | ||
| FCFM | N/A |
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y47.69%
ROICexc growth 3YN/A
ROICexc growth 5Y48.52%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
F-Score6
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 20.19 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 10.15 | ||
| Cap/Depr | 84.26% | ||
| Cap/Sales | 9.91% | ||
| Interest Coverage | 0.23 | ||
| Cash Conversion | 39.32% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.88 | ||
| Altman-Z | 1.14 |
F-Score6
WACC8.64%
ROIC/WACC0.09
Cap/Depr(3y)69.44%
Cap/Depr(5y)87.89%
Cap/Sales(3y)8.28%
Cap/Sales(5y)9.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.5%
EPS Next Y34.18%
EPS Next 2Y19.37%
EPS Next 3Y18.13%
EPS Next 5YN/A
Revenue 1Y (TTM)3.63%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.51%
Revenue Next Year2.75%
Revenue Next 2Y-0.46%
Revenue Next 3Y2.1%
Revenue Next 5YN/A
EBIT growth 1Y142.36%
EBIT growth 3YN/A
EBIT growth 5Y46.37%
EBIT Next Year517.25%
EBIT Next 3Y97.55%
EBIT Next 5YN/A
FCF growth 1Y-102.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2%
OCF growth 3YN/A
OCF growth 5Y-5.14%
BROOKDALE SENIOR LIVING - BKD 7 11/15/25 / BKDT FAQ
Can you provide the ChartMill fundamental rating for BROOKDALE SENIOR LIVING - BKD 7 11/15/25?
ChartMill assigns a fundamental rating of 2 / 10 to BKDT.
Can you provide the valuation status for BROOKDALE SENIOR LIVING - BKD 7 11/15/25?
ChartMill assigns a valuation rating of 1 / 10 to BROOKDALE SENIOR LIVING - BKD 7 11/15/25 (BKDT). This can be considered as Overvalued.
What is the profitability of BKDT stock?
BROOKDALE SENIOR LIVING - BKD 7 11/15/25 (BKDT) has a profitability rating of 3 / 10.
What is the earnings growth outlook for BROOKDALE SENIOR LIVING - BKD 7 11/15/25?
The Earnings per Share (EPS) of BROOKDALE SENIOR LIVING - BKD 7 11/15/25 (BKDT) is expected to grow by 34.18% in the next year.